Committed to Conquering Heart Failure

Focused on developing nanotherapeutics that target cannabinoids and other drugs to inflamed tissue in the heart. Cardiol’s proprietary nanoformulations offer the potential to prevent the chronic inflammatory processes that lead to the progression of heart failure.

Heart Failure Nanotherapeutics

Cardiol is using nanotechnology to develop treatments that address the chronic inflammation underlying heart failure.

CardiolRx Pharmaceutical Cannabidiol

Developing and manufacturing pharmaceutical cannabidiol to address the rapidly growing market for medicinal cannabinoids.

Science & Technology

Proprietary nanotherapeutics designed to enhance the solubilization, pharmacokinetics, and targeting of drugs to sites of disease.